Drugmakers are striving to reach probably the most efficient and non-invasive formulas to fight against heart diseases which recently have reached alarming quotas. Since high cholesterol is one of the factors that favor heart diseases, new generation of medicines target the reduction of risks via a much better control over high cholesterol.